The development of medical biotechnologies is one of the major success stories of the last 20 years, and continues to revolutionise the world of medicine. Exciting new developments have led the way to new treatments to combat previously life-threatening diseases and to improve the quality of life. This programme will lead you through some of the most important developments, helping you to understand them and opening up a future world of innovation and discovery.
Graduates of the programme will find rewarding careers in the pharmaceutical industry, as well as in the health sector and in public policy, as society grapples with the complex issues that the rapidly changing world of medical biotechnology brings with it.
With a focus on developing research skills, this programme equips you for further studies at Masters or even PhD level, that can lead to cutting edge medical biotechnology discovery.
This degree is validated by Lancaster University and upon successful completion of the programme, graduates are awarded two certificates; one from Sunway University and another from Lancaster University.
January, March & August
3 Years (full-time)
Average B- or CGPA 2.67 (Minimum 2 principals)
Minimum 14 points
Monash University Foundation Year
Sunway Foundation in Arts
Sunway Foundation in Science Technology
Unified Examination Certificate
Maximum 24 points from 5 subjects (all Grade Bs excluding Chinese and non-academic subjects)
Completed with minimum 26 points (excluding bonus points)
Pass 2 science subjects OR have experience/strong interest in biological sciences.
PTE Academic 50 overall (minimum 46 in each skill)
MUET Band 5
SPM English A2 or A-
UEC English B3
O-Level English (1119) B3
Sunway Intensive English Programme (IEP) Pass Level 4 with minimum 65%
ESL/English Satisfactory level in Pre-University programmes, where the medium of instruction is English
Note: Any other qualifications will be considered on a case-by-case basis.
*Sunway Diploma holders may obtain advanced standing if credit transfer requirements are met.